Insider Decision: Gary Charles Robb Offloads $225K Worth Of Corcept Therapeutics Stock

benzinga.com/insights/news/25/06/46015536/insider-decision-gary-charles-robb-offloads-225k-worth-of-corcept-therapeutics-stock

It was reported on June 18, that Gary Charles Robb, Chief Business Officer at Corcept Therapeutics CORT executed a significant insider sell, according to an SEC filing.
What Happened: Robb's recent Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday unveiled the…

This story appeared on benzinga.com, 2025-06-19 15:00:59.
The Entire Business World on a Single Page. Free to Use →